The expression levels of S100A8 or the heterodimer, S100A8/A9, are increased in tumor cells in multiple types of cancer, including gastric (8), colon (9) and pancreatic cancer (8), but rarely in RCC. This evidence concerns the gene IGKV1D-22 and renal cell carcinoma.